Stock Comparison
ARGX vs ASND
argenx NV ADR and Ascendis Pharma AS side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$17.10B
P/E (TTM)
39.4
30.3
Forward P/E
34.0
16.2
Price/Sales
11.7
19.8
Price/Book
7.5
30.9
EV/EBITDA
33.9
-20.8
Dividend Yield
—
—
Profitability
Net Margin
31.40%
57.30%
Operating Margin
30.00%
10.10%
Return on Equity
20.20%
33.30%
Return on Assets
8.86%
-0.60%
Growth (YoY)
Revenue Growth
62.60%
144.30%
Earnings Growth
114.00%
0.00%
Price & Risk
Beta
-0.0
0.5
52-Week High
$934.62
$271.89
52-Week Low
$510.06
$160.86
Analyst Target
$1,041.14
$291.15
Compare ARGX and ASND your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.